1. CXCL14 Maintains hESC Self-Renewal through Binding to IGF-1R and Activation of the IGF-1R Pathway
- Author
-
Chih-Lun Cheng, Shang-Chih Yang, Chien-Ying Lai, Cheng-Kai Wang, Ching-Fang Chang, Chun-Yu Lin, Wei-Ju Chen, Po-Yu Lin, Han-Chung Wu, Nianhan Ma, Frank Leigh Lu, and Jean Lu
- Subjects
CXCL14 ,BRAK ,BMAC ,Mip-2γ ,human embryonic stem cell ,self-renewal ,Cytology ,QH573-671 - Abstract
Human embryonic stem cells (hESCs) have important roles in regenerative medicine, but only a few studies have investigated the cytokines secreted by hESCs. We screened and identified chemokine (C-X-C motif) ligand 14 (CXCL14), which plays crucial roles in hESC renewal. CXCL14, a C-X-C motif chemokine, is also named as breast and kidney-expressed chemokine (BRAK), B cell and monocyte-activated chemokine (BMAC), and macrophage inflammatory protein-2γ (MIP-2γ). Knockdown of CXCL14 disrupted the hESC self-renewal, changed cell cycle distribution, and further increased the expression levels of mesoderm and endoderm differentiated markers. Interestingly, we demonstrated that CXCL14 is the ligand for the insulin-like growth factor 1 receptor (IGF-1R), and it can activate IGF-1R signal transduction to support hESC renewal. Currently published literature indicates that all receptors in the CXCL family are G protein-coupled receptors (GPCRs). This report is the first to demonstrate that a CXCL protein can bind to and activate a receptor tyrosine kinase (RTK), and also the first to show that IGF-1R has another ligand in addition to IGFs. These findings broaden our understanding of stem cell biology and signal transduction.
- Published
- 2020
- Full Text
- View/download PDF